{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:03:26Z","timestamp":1767171806666,"version":"build-2238731810"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["47\/03"],"award-info":[{"award-number":["47\/03"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["n.12214"],"award-info":[{"award-number":["n.12214"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-INT-2005-157276"],"award-info":[{"award-number":["RF-INT-2005-157276"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"0.5 per cent of taxes devolved by taxpayers to scientific research"},{"name":"Les Amis de Bordet.","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4558-4","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T22:25:19Z","timestamp":1528842319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7427-7032","authenticated-orcid":false,"given":"Elisabetta","family":"Venturelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Orenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline S. C.","family":"Fabricio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Garrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Agresti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Gion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Desmedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danila","family":"Coradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Biganzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"4558_CR1","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/bcr3117","volume":"14","author":"A Zeleniuch-Jacquotte","year":"2012","unstructured":"Zeleniuch-Jacquotte A, Afanasyeva Y, Kaaks R, Rinaldi S, Scarmo S, Liu M, et al. Premenopausal serum androgens and breast cancer risk: a nested case-control study. Breast Cancer Res. 2012;14:R32.","journal-title":"Breast Cancer Res"},{"key":"4558_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ijc.20403","volume":"112","author":"A Micheli","year":"2004","unstructured":"Micheli A, Muti P, Secreto G, Krogh V, Meneghini E, Venturelli E, et al. Endogenous sex hormones and subsequent breast cancer in pre-menopausal women. Int J Cancer. 2004;112:312.","journal-title":"Int J Cancer"},{"key":"4558_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1677\/erc.1.01038","volume":"12","author":"R Kaaks","year":"2005","unstructured":"Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer. 2005;12:1071.","journal-title":"Endocr Relat Cancer"},{"key":"4558_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjc.6601517","volume":"90","author":"A Zeleniuch-Jacquotte","year":"2004","unstructured":"Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmedkhanov A, Afanasyeva Y, Kato I, et al. Postmenopausal levels of estrogen, androgen, and SHBG and breast cancer risk: long-term results of a prospective study. r J Cancer. 2004;90:153.","journal-title":"r J Cancer"},{"key":"4558_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"TJ Key","year":"2002","unstructured":"Key TJ, Appleby PN, Reeves GK. Endogenous Hormones Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606.","journal-title":"J Natl Cancer Inst"},{"key":"4558_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1158\/1055-9965.EPI-08-0808","volume":"18","author":"S Sieri","year":"2009","unstructured":"Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomark Prev. 2009;18:169.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4558_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/jnci\/djr031","volume":"103","author":"GN Farhat","year":"2011","unstructured":"Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst. 2011;103:562.","journal-title":"J Natl Cancer Inst"},{"key":"4558_CR8","first-page":"105","volume-title":"Testosterone Reserch Trends","author":"G Secreto","year":"2007","unstructured":"Secreto G, Venturelli E, Pasanisi P, Berrino F. Androgens and breast cancer. The hyperandrogenic theory of breast cancer: past, present and future. In: Ardis LI, editor. Testosterone Reserch Trends. New York: Nova Science Publishers; 2007. p. 105\u201338."},{"key":"4558_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1158\/1055-9965.EPI-10-1240","volume":"20","author":"JA Emond","year":"2011","unstructured":"Emond JA, Patterson RE, Natarajan L, Laughlin GA, Gold EB, Pierce JP. Sex hormone concentrations and the risk of breast cancer recurrence in postmenopausal women without hot flashes. Cancer Epidemiol Biomark Prev. 2011;20:939.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4558_CR10","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1200\/JCO.2006.09.0118","volume":"25","author":"A Micheli","year":"2007","unstructured":"Micheli A, Meneghini E, Secreto G, Berrino F, Venturelli E, Cavalleri A, et al. Plasma testosterone and prognosis of postmenopausal breast Cancer patients. J Clin Oncol. 2007;25:2685.","journal-title":"J Clin Oncol"},{"key":"4558_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ijc.20582","volume":"113","author":"F Berrino","year":"2005","unstructured":"Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, et al. Serum testosterone levels and breast cancer recurrence. Int J Cancer. 2005;113:499.","journal-title":"Int J Cancer"},{"key":"4558_CR12","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/oby.2006.191","volume":"14","author":"A McTiernan","year":"2006","unstructured":"McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, et al. Women's Health Initiative investigators. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity. 2006;14:1662.","journal-title":"Obesity"},{"key":"4558_CR13","doi-asserted-by":"publisher","first-page":"E596","DOI":"10.1210\/jc.2014-2934","volume":"100","author":"ML Mongraw-Chaffin","year":"2015","unstructured":"Mongraw-Chaffin ML, Anderson CA, Allison MA, Ouyang P, Szklo M, Vaidya D, Woodward M, Golden SH. Association between sex hormones and adiposity: qualitative differences in women and men in the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab. 2015;100:E596.","journal-title":"J Clin Endocrinol Metab"},{"key":"4558_CR14","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1158\/1055-9965.EPI-09-0540","volume":"18","author":"G Secreto","year":"2009","unstructured":"Secreto G, Venturelli E, Meneghini E, Greco M, Ferraris C, Gion M, et al. Testosterone and biological characteristics of breast cancers in postmenopausal women. Cancer Epidemiol Biomark Prev. 2009;18:2942.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4558_CR15","doi-asserted-by":"publisher","unstructured":"Chan DS, Norat T. Obesity and breast cancer: not only a risk factor of the disease. Curr Treat Options in Oncol. 2015; \n                    https:\/\/doi.org\/10.1007\/s11864-015-0341-9\n                    \n                  .","DOI":"10.1007\/s11864-015-0341-9"},{"key":"4558_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/obr.12443","volume":"17","author":"GC Chen","year":"2016","unstructured":"Chen GC, Chen SJ, Zhang R, Hidayat K, Qin JB, Zhang YS, Qin LQ. Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies. Obes Rev. 2016;17:1167.","journal-title":"Obes Rev"},{"key":"4558_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13668-013-0068-9","volume":"3","author":"M Azrad","year":"2014","unstructured":"Azrad M, Demark-Wahnefried W. The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep. 2014;3:9.","journal-title":"Curr Nutr Rep"},{"key":"4558_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof A, Despr\u00e9s JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359.","journal-title":"Physiol Rev"},{"key":"4558_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS. Obesity and insulin resistance. Clin Invest. 2000;106:473.","journal-title":"Clin Invest"},{"key":"4558_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3322\/caac.21405","volume":"67","author":"M Picon-Ruiz","year":"2017","unstructured":"Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67:378.","journal-title":"CA Cancer J Clin"},{"key":"4558_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/oby.20974","volume":"23","author":"I Janssen","year":"2015","unstructured":"Janssen I, Powell LH, Jasielec MS, Kazlauskaite R. Covariation of change in bioavailable testosterone and adiposity in midlife women. Obesity. 2015;23:488.","journal-title":"Obesity"},{"key":"4558_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/oby.2009.251","volume":"18","author":"I Janssen","year":"2010","unstructured":"Janssen I, Powell LH, Kazlauskaite R, Dugan SA. Testosterone and visceral fat in midlife women: the study of Women\u2019s health across the nation (SWAN) fat patterning study. Obesity. 2010;18:604\u201310.","journal-title":"Obesity"},{"issue":"Suppl 1","key":"4558_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/humrep\/12.suppl_1.53","volume":"12","author":"JE Nestler","year":"1997","unstructured":"Nestler JE. Insulin regulation of human ovarian androgens. Hum Reprod. 1997;12(Suppl 1):53.","journal-title":"Hum Reprod"},{"key":"4558_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cen.12086","volume":"78","author":"R Wallace","year":"2013","unstructured":"Wallace R, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. Clin Endocrinol. 2013;78:321.","journal-title":"Clin Endocrinol"},{"key":"4558_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsbmb.2015.07.008","volume":"153","author":"X Wang","year":"2015","unstructured":"Wang X, Simpson ER, Brown KA. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer. J Steroid Biochem Mol Biol. 2015;153:35.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4558_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0009-8981(77)90276-5","volume":"80","author":"F Mean","year":"1977","unstructured":"Mean F, Pellaton M, Magrini G. Study of the binding of dihydrotestosterone, testosterone and oestradiol with sex hormone bunding globulin. Clin Chim Acta. 1977;80:171.","journal-title":"Clin Chim Acta"},{"key":"4558_CR27","first-page":"345","volume":"1836","author":"Y Hawsawi","year":"2013","unstructured":"Hawsawi Y, El-Gendy R, Twelves C, Speirs V, Beattie J. Insulin-like growth factor - oestradiol crosstalk and mammary gland tumourigenesis. Biochim Biophys Acta. 2013;1836:345.","journal-title":"Biochim Biophys Acta"},{"key":"4558_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.steroids.2012.11.001","volume":"78","author":"W Yue","year":"2013","unstructured":"Yue W, Yager JD, Wang JP, Jupe ER, Santen RJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids. 2013;78:161\u201370.","journal-title":"Steroids"},{"key":"4558_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5301\/JBM.2011.8883","volume":"26","author":"G Secreto","year":"2011","unstructured":"Secreto G, Meneghini E, Venturelli E, Cogliati P, Agresti R, Ferraris C, et al. Circulating sex hormones and tumour characteristics in postmenopausal breast cancer patients. A cross-sectional study. Int J Biol Markers. 2011;26:241.","journal-title":"Int J Biol Markers"},{"key":"4558_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/1471-2407-12-599","volume":"12","author":"G Secreto","year":"2012","unstructured":"Secreto G, Venturelli E, Meneghini E, Carcangiu ML, Paolini B, Agresti R, et al. Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers. BMC Cancer. 2012;12:599.","journal-title":"BMC Cancer"},{"issue":"Suppl 5","key":"4558_CR31","doi-asserted-by":"publisher","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. On behalf of the ESMO guidelines committee. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v8\u2013v30.","journal-title":"Ann Oncol"},{"key":"4558_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0167-9473(02)00122-6","volume":"42","author":"P Boracchi","year":"2003","unstructured":"Boracchi P, Biganzoli E, Marubini E. Joint modelling of cause-specific hazard functions with cubic splines: an application to a large series of breast cancer patients. Comput Stat Data Anal. 2003;42:243.","journal-title":"Comput Stat Data Anal"},{"key":"4558_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1258\/mi.2008.008015","volume":"14","author":"CL Shufelt","year":"2008","unstructured":"Shufelt CL, Braunstein GD. Testosterone and the breast. Menopause International. 2008;14:117.","journal-title":"Menopause International"},{"key":"4558_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.steroids.2011.10.002","volume":"77","author":"J Kotsopoulos","year":"2012","unstructured":"Kotsopoulos J, Narod SA. Androgens and breast cancer. Steroids. 2012;77:1.","journal-title":"Steroids"},{"issue":"1","key":"4558_CR35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.mce.2013.09.038","volume":"382","author":"N Patani","year":"2014","unstructured":"Patani N, Martin LA. Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer. Mol Cell Endocrinol. 2014 Jan 25;382(1):683\u201394.","journal-title":"Mol Cell Endocrinol"},{"key":"4558_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","volume":"62","author":"CK Osborne","year":"2011","unstructured":"Osborne CK, Schiff R. Mechanisms of endocrine resistance in breast cancer. Annu Rev Med. 2011;62:233.","journal-title":"Annu Rev Med"},{"key":"4558_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-009-0436-8","volume":"121","author":"F De Amicis","year":"2010","unstructured":"De Amicis F, Thirugnansampanthan J, Cui Y, Selever J, Beyer A, Parra I, et al. Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. 2010;121:1.","journal-title":"Breast Cancer Res Treat"},{"key":"4558_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-015-3609-7","volume":"154","author":"A Ciupek","year":"2015","unstructured":"Ciupek A, Rechoum Y, Gu G, Gelsomino L, Beyer AR, Brusco L, et al. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ER\u03b1-positive breast cancer. Breast Cancer Res Treat. 2015;154:225.","journal-title":"Breast Cancer Res Treat"},{"key":"4558_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10549-014-3082-8","volume":"147","author":"Y Rechoum","year":"2014","unstructured":"Rechoum Y, Rovito D, Iacopetta D, Barone I, And\u00f2 S, Weigel NL, et al. AR collaborates with ER\u03b1 in aromatase inhibitor-resistant breast cancer. Breast Cancer Res Treat. 2014;147:473.","journal-title":"Breast Cancer Res Treat"},{"key":"4558_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jsbmb.2014.08.019","volume":"144","author":"R Fujii","year":"2014","unstructured":"Fujii R, Hanamura T, Suzuki T, Gohno T, Shibahara Y, Niwa T, et al. Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma. J Steroid Biochem Mol Biol. 2014;144:513.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4558_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/719050.","volume":"2014","author":"J Rojas","year":"2014","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J, et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;2014:719050. \n                    https:\/\/doi.org\/10.1155\/2014\/719050.","journal-title":"Int J Reprod Med"}],"updated-by":[{"DOI":"10.1186\/s12885-018-4799-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4558-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T19:08:34Z","timestamp":1560366514000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4558-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4558"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4558-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,13]]},"assertion":[{"value":"24 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], the authors reported that the affiliation of author Annalisa Orenti was omitted.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of the Fondazione IRCCS Istituto Nazionale dei Tumori (protocol number 13\/225\/2003). Written informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"651"}}